Write in a clean editor, then format for Advances in Cancer Biology - Metastasis in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Advances in Cancer Biology - Metastasis is a peer-reviewed journal published by Elsevier, covering MicroRNA in disease regulation, Cancer Cells and Metastasis, Cancer-related molecular mechanisms research.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Advances in Cancer Biology - Metastasis 12 (2023) 45–58.
Formats any DOI in Advances in Cancer Biology - Metastasis style. No sign-up. |
| Publishes research in | MicroRNA in disease regulation Cancer Cells and Metastasis Cancer-related molecular mechanisms research Cancer, Hypoxia, and Metabolism Circular RNAs in diseases |
| ISSN | 2667-3940 |
| Citation impact (2-yr) | 2.62 |
| h-index | 21 |
| i10-index | 43 |
| Total citations | 1,493 |
| Article processing charge | $2,800 |
| Open access | Yes |
| Top institutions publishing here | Shahid Beheshti University of Medical Sciences |
| Journal website | www.journals.elsevier.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
A significant obstacle to treating cancer is multidrug resistance (MDR), which is the capacity of cancerous cells to develop resistance to both traditional and cutting-edge chemotherapeutic treatments. Following the initial discovery that cellular pumps reliant on ATP were the root of chemotherapy resistance, more research has revealed the involvement of additional mechanisms, including increased drug…
Breast cancer is a challenging health issue in women and the second-leading cause of mortality around world. In this review, we addressed beneficial role of siRNA to control breast cancer. Various limitations of siRNA based therapeutic approaches, innate challenges siRNA delivery, in vitro and in vivo findings have been highlighted to focus recent advancement to…
Baculoviral inhibitor of apoptosis repeat-containing 5 or BIRC5, member of the inhibitor of apoptosis (IAP), is a multitasking protein and among the top 100 deregulated genes in breast cancer patients. It negatively regulates apoptosis of tumor cells by inducing gene expression of anti-apoptotic proteins, promoting tumor cell proliferation, and modulates response to chemotherapeutics. The main…
Since ancient times, Moringa oleifera has been a common vegetable in many nations. It has a large number of phenolic compounds with a diverse range of biological activity. It has anticancer properties that can be exploited to create novel medications for the treatment of various malignancies. The current study was conducted to evaluate the in…
Treatment failure is one of the main hurdles in treating cervical cancer, despite significant breakthroughs in both conventional and targeted therapy. The one-year survival of patients with advanced or recurrent cervical cancer globally is less than 30%. Chemotherapy, radiation, and concurrent chemoradiotherapy are among the therapeutic modalities being used in clinics, depending on the stage…
